Tomorrow Capital, a Mumbai based $100 million venture capital fund , has exited from further investments in ZenoHealth (a generic medicine startup earlier known as Generico) to focus on other early stage investment opportunities. Backed by Abhinandan Lodha of Lodha Group, the fund has so far invested more than ₹100 crore over the last 3 years into four startups including ZenoHealth, Bonito Designs and Multiliving Technologies. The ₹13 crore investment in ZenoHealth was in the form of debt and equity. In case of ZenoHealth, Tomorrow Capital team worked with the founders and assisted them in scaling up the operations, setting up systems and processes and developing and implementing marketing playbook for new stores. The fund is currently looking at startups in the healthcare, fitness and education sector for the next round of early stage investments.

Source: Mint November 04, 2020 14:26 UTC